U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C21H25N3O3
Molecular Weight 367.4415
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of TIRACIZINE

SMILES

CCOC(=O)NC1=CC2=C(CCC3=CC=CC=C3N2C(=O)CN(C)C)C=C1

InChI

InChIKey=KJAMZCVTJDTESW-UHFFFAOYSA-N
InChI=1S/C21H25N3O3/c1-4-27-21(26)22-17-12-11-16-10-9-15-7-5-6-8-18(15)24(19(16)13-17)20(25)14-23(2)3/h5-8,11-13H,4,9-10,14H2,1-3H3,(H,22,26)

HIDE SMILES / InChI

Molecular Formula C21H25N3O3
Molecular Weight 367.4415
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Tiracizine a drug belongs to the new class I antiarrhythmic agent was studied in patients with ischemic heart disease, where was shown, that the drug could decrease myocardial contractile function.

Approval Year

PubMed

PubMed

TitleDatePubMed
Use dependent depression of fast sodium current in heart muscle by the new antiarrhythmic substance Bonnecor (AWD 19-166, GS 015).
1985 Dec
Patents

Patents

Sample Use Guides

7-day multiple-dose study period (50 mg tiracizine twice daily)
Route of Administration: Oral
Substance Class Chemical
Created
by admin
on Sat Dec 16 17:19:43 GMT 2023
Edited
by admin
on Sat Dec 16 17:19:43 GMT 2023
Record UNII
9UUO2T61K7
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
TIRACIZINE
INN   WHO-DD  
INN  
Official Name English
Tiracizine [WHO-DD]
Common Name English
tiracizine [INN]
Common Name English
Classification Tree Code System Code
WHO-VATC QC01EB11
Created by admin on Sat Dec 16 17:19:43 GMT 2023 , Edited by admin on Sat Dec 16 17:19:43 GMT 2023
WHO-ATC C01EB11
Created by admin on Sat Dec 16 17:19:43 GMT 2023 , Edited by admin on Sat Dec 16 17:19:43 GMT 2023
NCI_THESAURUS C47793
Created by admin on Sat Dec 16 17:19:43 GMT 2023 , Edited by admin on Sat Dec 16 17:19:43 GMT 2023
Code System Code Type Description
FDA UNII
9UUO2T61K7
Created by admin on Sat Dec 16 17:19:43 GMT 2023 , Edited by admin on Sat Dec 16 17:19:43 GMT 2023
PRIMARY
DRUG CENTRAL
2679
Created by admin on Sat Dec 16 17:19:43 GMT 2023 , Edited by admin on Sat Dec 16 17:19:43 GMT 2023
PRIMARY
ChEMBL
CHEMBL1625260
Created by admin on Sat Dec 16 17:19:43 GMT 2023 , Edited by admin on Sat Dec 16 17:19:43 GMT 2023
PRIMARY
MESH
C048166
Created by admin on Sat Dec 16 17:19:43 GMT 2023 , Edited by admin on Sat Dec 16 17:19:43 GMT 2023
PRIMARY
INN
6494
Created by admin on Sat Dec 16 17:19:43 GMT 2023 , Edited by admin on Sat Dec 16 17:19:43 GMT 2023
PRIMARY
CAS
83275-56-3
Created by admin on Sat Dec 16 17:19:43 GMT 2023 , Edited by admin on Sat Dec 16 17:19:43 GMT 2023
PRIMARY
DRUG BANK
DB13635
Created by admin on Sat Dec 16 17:19:43 GMT 2023 , Edited by admin on Sat Dec 16 17:19:43 GMT 2023
PRIMARY
EPA CompTox
DTXSID5048714
Created by admin on Sat Dec 16 17:19:43 GMT 2023 , Edited by admin on Sat Dec 16 17:19:43 GMT 2023
PRIMARY
WIKIPEDIA
TIRACIZINE
Created by admin on Sat Dec 16 17:19:43 GMT 2023 , Edited by admin on Sat Dec 16 17:19:43 GMT 2023
PRIMARY
PUBCHEM
71264
Created by admin on Sat Dec 16 17:19:43 GMT 2023 , Edited by admin on Sat Dec 16 17:19:43 GMT 2023
PRIMARY
NCI_THESAURUS
C75137
Created by admin on Sat Dec 16 17:19:43 GMT 2023 , Edited by admin on Sat Dec 16 17:19:43 GMT 2023
PRIMARY
EVMPD
SUB11114MIG
Created by admin on Sat Dec 16 17:19:43 GMT 2023 , Edited by admin on Sat Dec 16 17:19:43 GMT 2023
PRIMARY
SMS_ID
100000077265
Created by admin on Sat Dec 16 17:19:43 GMT 2023 , Edited by admin on Sat Dec 16 17:19:43 GMT 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY